GeoVax Labs, Inc.
GOVX
$1.28
-$0.06-4.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 852.30K | 1.64M | 864.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 852.30K | 1.64M | 864.40K |
| Cost of Revenue | 2.99M | 5.04M | 4.73M | 5.35M | 7.61M |
| Gross Profit | -2.99M | -5.04M | -3.88M | -3.72M | -6.74M |
| SG&A Expenses | 1.45M | 1.33M | 1.54M | 1.69M | 1.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.44M | 6.37M | 6.27M | 7.04M | 9.21M |
| Operating Income | -4.44M | -6.37M | -5.42M | -5.41M | -8.34M |
| Income Before Tax | -4.42M | -6.32M | -5.37M | -5.36M | -8.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.42M | -6.32M | -5.37M | -5.36M | -8.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.42M | -6.32M | -5.37M | -5.36M | -8.26M |
| EBIT | -4.44M | -6.37M | -5.42M | -5.41M | -8.34M |
| EBITDA | -4.42M | -6.36M | -5.40M | -5.39M | -8.32M |
| EPS Basic | -2.55 | -7.79 | -8.74 | -11.20 | -21.42 |
| Normalized Basic EPS | -1.59 | -4.87 | -5.46 | -7.00 | -13.39 |
| EPS Diluted | -2.55 | -7.79 | -8.74 | -11.20 | -21.42 |
| Normalized Diluted EPS | -1.59 | -4.87 | -5.46 | -7.00 | -13.39 |
| Average Basic Shares Outstanding | 1.73M | 811.50K | 614.40K | 478.20K | 385.80K |
| Average Diluted Shares Outstanding | 1.73M | 811.50K | 614.40K | 478.20K | 385.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |